Poster Abstract Session:
045. Clinical: Bone and Joint Infection
Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Low Rate of Microbiologic Relapse in Two Stage Exchange for Hip Prosthetic Joint Infections
Michael Henry, MD; Celeste Russell, MPH; Allina Nocon, PhD; Geoffrey Westrich, MD; Barry Brause, MD; Andy Miller, MD
Clinical Characteristics and Outcomes of Healthcare-Associated Hematogenous Vertebral Osteomyelitis
Ki-Ho Park, MD; Yu-Mi Lee, MD; Song Mi Moon, M.D., Ph.D.; Seong Yeon Park, MD; Oh-Hyun Cho, MD; Mi Suk Lee, M.D.; In-Gyu Bae, MD
The Spectrum of Pediatric Osteoarticular Infections: A Comparative Study
Zaid Alhinai, MD; Morvarid Elahi, MD; Bill Foo, MD; Brian Lee, MD; Kimberle C. Chapin, MD; Penelope H. Dennehy, MD, FIDSA, FPIDS; Michael Koster, MD; Pablo J. Sanchez, MD, FIDSA, FPIDS; Ian C. Michelow, MD, DTM&H
Utility of Diagnostic Bone Biopsies in the Management of Osteomyelitis through Retrospective Analysis: How Golden is this Gold Standard?
Cole Hirschfeld, BS; Shashi Kapadia, MD; Joanna Bryan, MPH; Deanna Jannat-Khah, MSPH, DrPH; Benjamin May, MD; Tamir Friedman, MD; Ole Vielemeyer, MD; Ernie Esquivel, MD
  • IDWeek 2017 Poster Final.pdf (1.3 MB)
  • 199
    Comparative Analysis of Initial Antibiotic Dosing Among Healthy Weight, Overweight, and Obese Children with Osteomyelitis
    Joel Waddell, DO; Russell Mcculloh, MD; Jennifer Goldman, MD, MS; Brian Lee, MPH, PhD; Warren Teachout, BS
  • IDWeek2017-Joel Waddell.pdf (212.1 kB)
  • 200
    Septic Arthritis of Native Joints: Are Outcomes Better with Medical or Surgical Management?
    Ian McConnell, MD; Adam Baghban, MD; Jurgen Holleck, MD; Shaili Gupta, MD
    Factors Associated with Success in Revision Surgery for Infected Hip and Knee Arthroplasties
    Christopher Kandel, MD; David Backstein, MD, MEd, FRCS(C); Abhilash Sajja, BSc, MD; Allison McGeer, MD, MSc
    Assessment of a Modified Antibiotic Prophylaxis Open Fracture Protocol
    Brandon Hill, PharmD; Kamla Sanasi-Bhola, MD; Stella Okoye, MD; Margaret Madera, PharmD Candidate; Janie Ferren, PharmD Candidate; Julie Ann Justo, PharmD, MS, BCPS-AQ ID; P. Brandon Bookstaver, PharmD, FCCP, FIDSA, AAHIVP
  • Hill_AOFP_IDWeek2017FINAL.pdf (359.6 kB)
  • 204
    Pubic Osteomyelitis: Epidemiology and Factors Associated with Management Failure in Two French Reference Centers
    Tristan Ferry, MD, PhD; Agathe Becker, MD; Florent Valour, MD, PhD; Thomas Perpoint, MD; Loic Boussel, MD, PhD; Alain Ruffion, MD, PhD; Frederic Laurent, DPharm, PhD; Eric Senneville, MD, PhD; Christian Chidiac, MD, PhD
    Reexamining BSA as a Preoperative Predictor of Risk of Prosthetic Joint Infection
    Celeste Russell, MPH; Allina Nocon, PhD; David Mayman, MD; Geoffrey Westrich, MD; Andy Miller, MD; Barry Brause, MD; Michael Henry, MD
    Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Patients with Diabetes Mellitus
    Michael Nowak, PharmD; Urania Rappo, MD, MS, PharmD; Pedro L. Gonzalez, MD; Jie Chen, PhD; Jennifer S. McGregor, RPh; Jason Bryowsky, PharmD; David Talan, MD
    Corynebacterium Bone and Joint Infection (BJI): A Retrospective Cohort Study in a Reference Center for BJI Management
    Tristan Ferry, MD, PhD; Pierre Chauvelot, Resident; Claire Triffault-Fillit, MD; Evelyne Braun, MD; Thomas Perpoint, MD; Frederic Laurent, DPharm, PhD; Michel-Henri Fessy, MD, PhD; Sébastien Lustig, MD, PhD; Christian Chidiac, MD, PhD; Florent Valour, MD, PhD
    Microbiological Epidemiology Depending on Time to Occurrence of Prosthetic Joint Infection (PJI): Impact on the Empirical Antimicrobial Strategies.
    Tristan Ferry, MD, PhD; Claire Triffault-Fillit, MD; Frederic Laurent, DPharm, PhD; Céline Dupieux, PharmD; Sébastien Lustig, MD, PhD; Michel-Henri Fessy, MD, PhD; Christian Chidiac, MD, PhD; Florent Valour, MD, PhD
    Clinical Characteristics and Treatment Outcomes of Patients with Sternoclavicular Septic Arthritis Caused by Staphylococcus aureus
    Byunghan Ryu, MD; Young-Rock Jang, MD; Seung Hyun Lee, MD; Jeongmin Hong, MD; Min-Chul Kim, MD; Min Jae Kim, MD; Heungsup Sung, MD, PhD; Mi-Na Kim, MD, PhD; Sung-Han Kim, MD, PhD; Sang-Oh Lee, MD, PhD; Sang-Ho Choi, MD, PhD; Jin-Yong Jeong, PhD; Yang Soo Kim, MD, PhD; Jun Hee Woo, MD, PhD; Yong Pil Chong, MD, PhD
    Oral Versus Intravenous Antibiotics for the Treatment of Acute Bacterial Osteomyelitis in the Veteran Population
    Caitlin Turnbull, Pharm.D., BCPS; Lisa Young, PharmD, BCPS AQ-ID; Sheryl Lowery, Pharm.D., BCPS
    Multidrug-Resistant Gram-negative bacilli prosthetic joint infection: a worrisome scenario.
    Taiana Ribeiro, Medical; Giselle Klautau, Md; Mauro Salles, Md
    Predictive Factors for Successful Treatment in Candidial Bone & Joint Infection
    Wooyong Jeong, MD; In Young Jung, MD; Heun Choi, MD; Jinnam Kim, MD; Se Ju Lee, MD; Hye Seong, MD; Jung Ju Kim, MD; Nam Su Ku, MD, PhD; Jun Yong Choi, MD, PhD; Young Goo Song, MD, PhD; June Myung Kim, MD, PhD; Su Jin Jeong, MD/PhD
    The Influence of Obesity on the Infection Risk of Prosthetic Joint Infection in the Geriatric Orthopedic Population
    Allina Nocon, PhD; Michael Henry, MD; Celeste Russell, MPH; Geoffrey Westrich, MD; Barry Brause, MD; Andy Miller, MD
    Subcutaneous Suppressive Antibiotic Therapy for Bone and Joints Infections : Safety and Outcome in a Cohort of 10 Patients
    Tristan Ferry, MD, PhD; Cecile Pouderoux, Resident; Sylvain Goutelle, DPharm, PhD; Sébastien Lustig, MD, PhD; Claire Triffault-Fillit, MD; Fatiha Daoud, MD; Michel-Henri Fessy, MD, PhD; Sabine Cohen, DPharm, PhD; Frederic Laurent, DPharm, PhD; Christian Chidiac, MD, PhD; Florent Valour, MD, PhD
    Microbiological Epidemiology in Patients Experiencing Microbiological or Clinical Failure Following Reimplantation After a 2-stage Exchange Strategy for Hip or Knee Prosthetic Joint Infection (PJI)
    Tristan Ferry, MD, PhD; Hassan Serrier, MD; Frederic Laurent, DPharm, PhD; Eugenie Mabrut, CRA; Michel-Henri Fessy, MD, PhD; Christian Chidiac, MD, PhD; Laure Huot, MD; Sébastien Lustig, MD, PhD; Florent Valour, MD, PhD
    Pressure Ulcer-Related Pelvic Osteomyelitis: Evaluation of a Two-Stage Surgical Strategy (Debridement, Negative Pressure Therapy and Flap Coverage) with Prolonged Antimicrobial Therapy
    Tristan Ferry, MD, PhD; Fabien Boucher, MD; Joseph Chateau, MD; Hristo Shipkov, MD; Fatiha Daoud, MD; Evelyne Braun, MD; Claire Triffault-Fillit, MD; Thomas Perpoint, MD; Frederic Laurent, DPharm, PhD; Alain-Ali Mojallal, MD, PhD; Christian Chidiac, MD, PhD; Florent Valour, MD, PhD; Johan Andrianasolo, MD
    Microbiologic Predictors of Pelvic Osteomyelitis Related to Decubitus Ulcers
    Neha Sharma, BS; Abbye Clark, BS; Caroline Derrick, PharmD, BCPS; Majdi N. Al-Hasan, MBBS; Sharon Weissman, MD; Kamla Sanasi-Bhola, MD
  • ID Week PO-Sharma FINAL .pdf (215.0 kB)
  • 226
    Clinical and Epidemiological Aspects Related to Infection of Orthopedic Prostheses in Argentinean Children. A Ten-years Period Study.
    Carlos Mauricio Vergara Lobo, MD; Fausto M Ferolla, MD; Elen Contreras, MD; Carolina Carballo, MD; Walter Yfran, MD; Eugenia Pannunzio, MD; Eliana Anteliz, MD; Juan Reviriego, MD; Maria Escalada, MD; Gabriel Rositto, MD; Carlos Legarreta, MD; Claudia I. Cazes, MD; María M. Contrini, MD; Eduardo L Lopez, MD
  • IMG_0787.PNG (698.2 kB)
  • 227
  • SAK IDweek.pdf (486.5 kB)
  • 228
    The Use of Rifampin Therapy to Treat Diabetic Patients with Osteomyelitis of the Foot in the Veterans Health Administration: Patient Characteristics and Clinical Outcomes
    Brigid Wilson, PhD; Elie Saade, MD, MPH; Gheorghe Doros, PhD; John Hermos, MD; Mary Bessesen, MD; Robert A. Bonomo, MD
    Recent Respiratory Tract Infection and Additional surgeries Increase Risk for Surgical Site Infection in Total Joint Arthroplasty: A Retrospective Analysis of 2255 patients
    Bhagyashri Navalkele, MD; Amar Krishna, MD; George McKelvey, PhD; Samuel Perov, MD; Kunal Sood, MD; Youssef Dakallah, MD; Teena Chopra, MD, MPH

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.